Patents

US 12312376 B2: Therapeutic double stranded RNA and methods for producing the same

Granted
2025-05-27
Filed
2021-01-25 application 17773545
Type
Utility · 8 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Disclosed is a method for the synthesis of a therapeutic double-stranded RNA (tdsRNA), comprising: a) synthesizing a first single-stranded RNA (first ssRNA) in a first synthesis reaction with PNPase as the only RNA polymerase; b) synthesizing a second single-stranded RNA (second ssRNA) in a second synthesis reaction with PNPase as the only RNA polymerase; and c) hybridizing the first ssRNA with the second ssRNA to form the tdsRNA; wherein step a) and step b) are performed in any order. Also disclosed is a product produced by the method.

Source: PVGPATDIS, file of 2026-04-10 (ipg250527.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
AIM ImmunoTech Inc. 6 patentsUS company or organizationOcala, FLAIM IMMUNOTECH INC. State business registration EXACT high confidence: identical full name and state
AIM ImmunoTech Inc. Form D issuer EXACT high confidence: identical full name and state
AIM IMMUNOTECH INC. SEC filer EXACT medium confidence: identical full name, one of each nationally
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Thomas K. EQUELSOcala, FL5Person page FUZZY medium confidencePVGPATDIS, file of 2026-04-10
Vishwajeetsinh M. AtodariaAdams, NJ1PVGPATDIS, file of 2026-04-10
Victoria ScottLanghorne, PA1PVGPATDIS, file of 2026-04-10
David StrayerBryn Mawr, PA11PVGPATDIS, file of 2026-04-10
Peter W. RodinoFort Myers, FL1PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07HSugars; derivatives thereof; nucleosides; nucleotides; nucleic acidsC07H21/02PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K31/713PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P31/14PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N15/10PVGPATDIS, file of 2026-04-10
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixtureC12P19/34PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2022-04-29Assignment
Assignment of assignor's interest
ATODARIA, VISHWAJEETSINH M. signed 2021-03-05
SCOTT, VICTORIA G. signed 2021-03-05
EQUELS, THOMAS K. signed 2021-03-08
RODINO, PETER W. signed 2021-03-08
STRAYER, DAVID R. signed 2021-03-23
AIM IMMUNOTECH INC. OCALA, FL59717/262ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.